The predictive efficacy of tumor mutation burden in immunotherapy across multiple cancer types: A meta-analysis and bioinformatics analysis
Purpose: To explore the predictive efficacy of tumor mutation burden (TMB) as a potential biomarker for cancer patients treated with Immune checkpoint inhibitors (ICIs). Methods: We systematically searched PubMed, Cochrane Library, Embase and Web of Science for clinical studies (published between Ja...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2022-06-01
|
| Серія: | Translational Oncology |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S1936523322000377 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
